Avacta Group (AVCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Sep 2010 05:08 PM
PRN
Holding(s) in Company
06 Sep 2010 07:00 AM
PRN
Distribution Agreement
06 Aug 2010 09:55 AM
PRN
Director/PDMR Shareholding
29 Jul 2010 07:00 AM
PRN
Issue of Equity
06 Jul 2010 07:00 AM
PRN
Issue of Equity
01 Jun 2010 07:00 AM
PRN
Change of Adviser
30 Apr 2010 07:00 AM
PRN
Half-yearly Report
08 Mar 2010 07:00 AM
RNS
Notice of Results and Trading
03 Mar 2010 07:00 AM
RNS
Acquisition
22 Feb 2010 02:42 PM
RNS
Director/PDMR Shareholding
25 Jan 2010 07:00 AM
RNS
Result of AGM
21 Dec 2009 10:35 AM
RNS
Issue of Equity
26 Nov 2009 07:03 AM
RNS
Preliminary Results
26 Nov 2009 07:00 AM
RNS
Issue of Equity
04 Nov 2009 07:00 AM
PRN
Notice of Results
21 Oct 2009 07:00 AM
PRN
Placing and Issue of Equity
06 Oct 2009 07:00 AM
RNS
Optim - Second Order
28 Sep 2009 07:00 AM
PRN
Re Agreement
16 Sep 2009 03:03 PM
RNS
Holding(s) in Company
11 Sep 2009 04:26 PM
RNS
Holding(s) in Company
11 Sep 2009 03:59 PM
RNS
Holding(s) in Company
07 Aug 2009 07:00 AM
PRN
Pre-Close Trading Statement
28 Jul 2009 05:07 PM
RNS
Holding(s) in Company
13 Jul 2009 04:40 PM
RNS
Director/PDMR Shareholding
10 Jul 2009 04:17 PM
RNS
Issue of Equity
09 Jul 2009 04:29 PM
RNS
Further re Acquisition of The
23 Apr 2009 07:00 AM
RNS
Half Yearly Report
23 Apr 2009 07:00 AM
PRN
OPTIM Product Launch
31 Mar 2009 12:20 PM
PRN
Analyst Presentation
30 Mar 2009 12:59 PM
PRN
Director/PDMR Shareholding
03 Mar 2009 01:17 PM
RNS
Completion of Acquisition of
12 Feb 2009 01:23 PM
RNS
Rule 8.1- (Curidium Medica Pl
09 Feb 2009 12:39 PM
RNS
Result of EGM
09 Feb 2009 07:00 AM
PRN
Acquisition
26 Jan 2009 07:00 AM
PRN
Result of AGM
15 Jan 2009 09:24 AM
PRN
Acquisition of Theragenetics Limited
09 Jan 2009 07:00 AM
PRN
Acquisition(s)
08 Jan 2009 02:29 PM
RNS
Director/PDMR Shareholding
07 Jan 2009 07:00 AM
RNS
Issue of Equity
12 Dec 2008 12:06 PM
RNS
Final Results
20 Nov 2008 04:14 PM
RNS
Director/PDMR Shareholding
05 Nov 2008 12:42 PM
RNS
Issue of Equity
04 Nov 2008 07:00 AM
PRN
Final Results
13 Oct 2008 07:00 AM
PRN
Change of Adviser
11 Sep 2008 07:00 AM
PRN
Product Launch
21 Aug 2008 07:00 AM
PRN
Trading Statement
14 Aug 2008 11:03 AM
PRN
Product Development Partnership
28 Jul 2008 07:00 AM
PRN
Product Launch
23 Jul 2008 02:54 PM
PRN
Director/PDMR Shareholding
22 Jul 2008 04:24 PM
PRN
Director/PDMR Shareholding

Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics.

It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.

Avacta Group share price launched at 5,448p in 2003. 

UK 100

Latest directors dealings